港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

友芝友生物-B

7.150

0.000

成交量：5,600.00

成交額：3.77萬

市值：13.86億

市盈率：-14.20

高：7.150

開：7.150

低：7.150

收：7.150

52周最高：8.350

52周最低：4.000

股本：1.94億

香港流通股本：1.11億

量比：3.04

換手率：0.01%

股息：- -

股息率：- -

每股收益(LYR):-0.503

淨資產收益率：-704.81%

總資產收益率：-18.74%

市淨率：-44.88

市盈率(LYR):-14.20

市銷率: 8.25

資料載入中...

總覽公司新聞資訊公告

友芝友生物-B(02496)：公司H股全流通獲聯交所授出上市批准

智通财经网

友芝友生物-B宣佈M701獲FDA臨床試驗批准

友芝友生物-B(02496)：M 701取得FDA的IND批准

友芝友生物-B盤中異動急速上漲7.61%

友芝友生物-B(02496)：中國證監會就公司H股全流通發出備案通知

友芝友生物(02496.HK)作價3,688萬人民幣出售武漢工業地

阿斯达克财经

友芝友生物-B(02496)擬3688萬元轉讓武漢市東湖新技術開發區土地使用權及建築物

上市公司十強出爐，武大華科誰贏了

友芝友生物-B(02496)：石劍獲選舉為職工代表監事

友芝友生物(02496.HK)生物類似藥Y225臨床試驗申請獲批

阿斯达克财经

友芝友生物-B(02496)：Y225(艾美賽珠單抗注射液)取得NMPA的IND批准

智通港股早知道 | 特朗普稱哈塞特為「潛在的」聯儲局主席蘋果(AAPL.US)續創歷史新高

友芝友生物-B(02496)於《實驗血液學與腫瘤學》上發表M 701惡性腹水II期數據

深耕雙抗領域15年，友芝友生物周鵬飛：中國創新藥正在走向產業高潮

新藥周觀點：ESMO2025國產新藥精彩紛呈

ORR 72.7%！友芝友生物EpCAM×CD3雙抗II期研究中期數據公布

生物药大时代

友芝友生物-B(02496)：M701惡性胸水II期研究中期數據在2025年ESMO會議上公布

友芝友生物-B盤中異動早盤快速拉升5.24%

友芝友生物-B(02496)：王濤獲選舉為職工代表監事

友芝友生物-B(02496)發布中期業績，淨虧損5883.4萬元，按年收窄25%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02496/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02496","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"友芝友生物-B","latestPrice":7.15,"timestamp":1772522357704,"preClose":7.15,"halted":0,"volume":5600,"delay":0,"changeRate":0,"floatShares":111468814,"shares":193849200,"eps":-0.503479,"marketStatus":"已收盤","change":0,"latestTime":"03-03 15:19:17","open":7.15,"high":7.15,"low":7.15,"amount":37664,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.441123,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772587800000},"marketStatusCode":5,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":7.15,"openAndCloseTimeList":[[1772501400000,1772510400000],[1772514000000,1772524800000]],"volumeRatio":3.043478,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","floatShares":111468814,"roa":"-18.74%","roe":"-704.81%","lyrEps":-0.503479,"volumeRatio":3.043478,"shares":193849200,"dividePrice":0,"high":7.15,"amplitude":0,"preClose":7.15,"low":7.15,"week52Low":4,"pbRate":"-44.88","psRate":"8.25","week52High":8.35,"institutionHeld":0,"latestPrice":7.15,"eps":-0.503479,"divideRate":0,"volume":5600,"delay":0,"ttmEps":-0.441123,"open":7.15,"prevYearClose":8.02,"prevWeekClose":6.52,"prevMonthClose":6.52,"prevQuarterClose":8.02,"fiveDayClose":7.24,"twentyDayClose":7.87,"sixtyDayClose":7.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02496\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-28","symbol":"02496","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盤後","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-29","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724895000000,"name":null,"time":"","dateTimestamp":1724860800000,"actualEps":null},{"date":"2024-03-28","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null},{"date":"2023-09-28","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1695864600000,"name":null,"time":"","dateTimestamp":1695830400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02496\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02496\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02496\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02496","date":"2026-03-02","current":-16.208631,"percent":0.148581,"low":-18.565593,"twenty":-14.567492,"median":-8.178873,"eighty":-6.907541,"high":-3.741546,"avg":-9.47059,"sd":3.847171,"marketCap":1386021780},"quantilePoints":[{"date":"2023-09-22","current":-15.261024,"twenty":-15.274233,"median":-15.26928,"eighty":-15.264326,"marketCap":3088019200},{"date":"2023-09-29","current":-15.292224,"twenty":-17.099581,"median":-15.293234,"eighty":-15.280473,"marketCap":3049418960},{"date":"2023-10-06","current":-15.493216,"twenty":-15.501023,"median":-15.292224,"eighty":-15.050323,"marketCap":3088019200},{"date":"2023-10-13","current":-15.380625,"twenty":-15.493216,"median":-15.348538,"eighty":-15.261024,"marketCap":3060999032},{"date":"2023-10-20","current":-10.535817,"twenty":-15.418704,"median":-15.300038,"eighty":-14.801616,"marketCap":2093571360},{"date":"2023-10-27","current":-9.759574,"twenty":-15.417248,"median":-15.292224,"eighty":-11.937608,"marketCap":1938492000},{"date":"2023-11-03","current":-9.733728,"twenty":-15.412338,"median":-15.155674,"eighty":-10.478048,"marketCap":1938492000},{"date":"2023-11-10","current":-8.275398,"twenty":-15.390041,"median":-14.508961,"eighty":-9.494912,"marketCap":1647718200},{"date":"2023-11-17","current":-8.703164,"twenty":-15.38145,"median":-11.695259,"eighty":-8.750672,"marketCap":1748519784},{"date":"2023-11-24","current":-8.421561,"twenty":-15.329285,"median":-10.573898,"eighty":-8.701771,"marketCap":1705872960},{"date":"2023-12-01","current":-7.919793,"twenty":-15.30332,"median":-10.003273,"eighty":-8.541365,"marketCap":1610886852},{"date":"2023-12-08","current":-8.497372,"twenty":-15.294595,"median":-9.516549,"eighty":-8.420238,"marketCap":1721380896},{"date":"2023-12-15","current":-8.258301,"twenty":-15.292426,"median":-9.276148,"eighty":-8.274722,"marketCap":1682611056},{"date":"2023-12-22","current":-8.349506,"twenty":-15.280473,"median":-8.776546,"eighty":-8.277258,"marketCap":1700057484},{"date":"2023-12-29","current":-8.428335,"twenty":-15.270931,"median":-8.740745,"eighty":-8.306436,"marketCap":1725257880},{"date":"2024-01-05","current":-8.249766,"twenty":-15.218884,"median":-8.699682,"eighty":-8.272694,"marketCap":1676795580},{"date":"2024-01-12","current":-8.302569,"twenty":-15.000582,"median":-8.571321,"eighty":-8.275563,"marketCap":1688426532},{"date":"2024-01-19","current":-8.113537,"twenty":-14.743085,"median":-8.513713,"eighty":-8.272694,"marketCap":1647718200},{"date":"2024-01-26","current":-7.982332,"twenty":-14.471602,"median":-8.481448,"eighty":-8.258393,"marketCap":1614763836},{"date":"2024-02-02","current":-7.992522,"twenty":-13.915342,"median":-8.424948,"eighty":-8.196137,"marketCap":1614763836},{"date":"2024-02-09","current":-8.02019,"twenty":-12.050937,"median":-8.406699,"eighty":-8.080173,"marketCap":1628333280},{"date":"2024-02-16","current":-8.343013,"twenty":-11.339581,"median":-8.370574,"eighty":-8.105196,"marketCap":1694242008},{"date":"2024-02-23","current":-8.30086,"twenty":-10.803844,"median":-8.369483,"eighty":-8.124586,"marketCap":1676795580},{"date":"2024-03-01","current":-8.247733,"twenty":-10.604956,"median":-8.362825,"eighty":-8.153154,"marketCap":1667103120},{"date":"2024-03-08","current":-8.186551,"twenty":-10.543433,"median":-8.343013,"eighty":-8.173812,"marketCap":1655472168},{"date":"2024-03-15","current":-8.155425,"twenty":-10.30474,"median":-8.311389,"eighty":-8.173276,"marketCap":1647718200},{"date":"2024-03-22","current":-7.39462,"twenty":-9.857053,"median":-8.302569,"eighty":-8.105196,"marketCap":1492638840},{"date":"2024-03-28","current":-7.61103,"twenty":-9.744066,"median":-8.301568,"eighty":-8.043049,"marketCap":1531408680},{"date":"2024-04-05","current":-7.288366,"twenty":-9.690292,"median":-8.300787,"eighty":-8.021295,"marketCap":1512023760},{"date":"2024-04-12","current":-6.976051,"twenty":-9.494912,"median":-8.295352,"eighty":-7.983468,"marketCap":1448053524},{"date":"2024-04-19","current":-6.963318,"twenty":-9.388856,"median":-8.276973,"eighty":-7.977458,"marketCap":1444176540},{"date":"2024-04-26","current":-6.971914,"twenty":-9.296949,"median":-8.272018,"eighty":-7.930221,"marketCap":1444176540},{"date":"2024-05-03","current":-6.976736,"twenty":-9.241479,"median":-8.264756,"eighty":-7.6347,"marketCap":1444176540},{"date":"2024-05-10","current":-6.960212,"twenty":-8.933122,"median":-8.256463,"eighty":-7.598809,"marketCap":1444176540},{"date":"2024-05-17","current":-6.970443,"twenty":-8.807861,"median":-8.251559,"eighty":-7.39462,"marketCap":1444176540},{"date":"2024-05-24","current":-7.095514,"twenty":-8.76114,"median":-8.247733,"eighty":-7.267873,"marketCap":1444176540},{"date":"2024-05-31","current":-7.0883,"twenty":-8.730819,"median":-8.237322,"eighty":-7.171233,"marketCap":1444176540},{"date":"2024-06-07","current":-7.097101,"twenty":-8.707372,"median":-8.195562,"eighty":-7.097101,"marketCap":1444176540},{"date":"2024-06-14","current":-7.132215,"twenty":-8.698985,"median":-8.193432,"eighty":-7.097238,"marketCap":1449992016},{"date":"2024-06-21","current":-7.988022,"twenty":-8.625304,"median":-8.18531,"eighty":-7.098087,"marketCap":1620579312},{"date":"2024-06-28","current":-7.48471,"twenty":-8.574009,"median":-8.177364,"eighty":-7.098775,"marketCap":1517839236},{"date":"2024-07-05","current":-7.715801,"twenty":-8.562528,"median":-8.159606,"eighty":-7.101937,"marketCap":1564363044},{"date":"2024-07-12","current":-7.141207,"twenty":-8.536784,"median":-8.120442,"eighty":-7.107036,"marketCap":1449992016},{"date":"2024-07-19","current":-7.131527,"twenty":-8.514561,"median":-8.053748,"eighty":-7.107036,"marketCap":1448053524},{"date":"2024-07-26","current":-7.10513,"twenty":-8.504633,"median":-8.029564,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-02","current":-7.109273,"twenty":-8.491002,"median":-8.019114,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-09","current":-7.033842,"twenty":-8.475712,"median":-7.991974,"eighty":-7.097834,"marketCap":1442238048},{"date":"2024-08-16","current":-6.879903,"twenty":-8.451599,"median":-7.985142,"eighty":-7.095806,"marketCap":1411222176},{"date":"2024-08-23","current":-6.041633,"twenty":-8.425625,"median":-7.981406,"eighty":-7.090359,"marketCap":1244511864},{"date":"2024-08-30","current":-6.047183,"twenty":-8.418914,"median":-7.97694,"eighty":-7.085583,"marketCap":1219311468},{"date":"2024-09-06","current":-6.034663,"twenty":-8.411646,"median":-7.942728,"eighty":-7.024202,"marketCap":1217372976},{"date":"2024-09-13","current":-6.050501,"twenty":-8.400619,"median":-7.919793,"eighty":-6.989131,"marketCap":1217372976},{"date":"2024-09-20","current":-5.899508,"twenty":-8.390451,"median":-7.809695,"eighty":-6.977241,"marketCap":1194111072},{"date":"2024-09-27","current":-5.635763,"twenty":-8.383344,"median":-7.722148,"eighty":-6.974189,"marketCap":1147587264},{"date":"2024-10-04","current":-6.646499,"twenty":-8.371665,"median":-7.71452,"eighty":-6.971914,"marketCap":1347251940},{"date":"2024-10-10","current":-6.670566,"twenty":-8.369919,"median":-7.665604,"eighty":-6.970443,"marketCap":1343374956},{"date":"2024-10-18","current":-5.989499,"twenty":-8.366581,"median":-7.61103,"eighty":-6.964903,"marketCap":1199926548},{"date":"2024-10-25","current":-5.941495,"twenty":-8.363757,"median":-7.592567,"eighty":-6.963278,"marketCap":1190234088},{"date":"2024-11-01","current":-5.753759,"twenty":-8.362581,"median":-7.48471,"eighty":-6.932913,"marketCap":1153402740},{"date":"2024-11-08","current":-5.323409,"twenty":-8.352088,"median":-7.478194,"eighty":-6.706839,"marketCap":1062293616},{"date":"2024-11-15","current":-4.810927,"twenty":-8.344312,"median":-7.39462,"eighty":-6.66868,"marketCap":949861080},{"date":"2024-11-22","current":-4.597104,"twenty":-8.320901,"median":-7.288282,"eighty":-6.614502,"marketCap":907214256},{"date":"2024-11-29","current":-4.511723,"twenty":-8.314189,"median":-7.193914,"eighty":-6.4628,"marketCap":889767828},{"date":"2024-12-06","current":-3.832688,"twenty":-8.309887,"median":-7.189483,"eighty":-6.054759,"marketCap":754073388},{"date":"2024-12-13","current":-3.741546,"twenty":-8.30727,"median":-7.147179,"eighty":-6.049837,"marketCap":734688468},{"date":"2024-12-20","current":-3.946605,"twenty":-8.303428,"median":-7.141207,"eighty":-6.034627,"marketCap":771519816},{"date":"2024-12-27","current":-6.936731,"twenty":-8.302316,"median":-7.140369,"eighty":-6.034555,"marketCap":1355005908},{"date":"2025-01-03","current":-7.8123,"twenty":-8.301863,"median":-7.141207,"eighty":-6.034663,"marketCap":1527531696},{"date":"2025-01-10","current":-7.782302,"twenty":-8.301426,"median":-7.145546,"eighty":-6.036057,"marketCap":1515900744},{"date":"2025-01-17","current":-7.348445,"twenty":-8.300831,"median":-7.189317,"eighty":-6.042743,"marketCap":1432545588},{"date":"2025-01-24","current":-7.302687,"twenty":-8.300293,"median":-7.192391,"eighty":-6.047847,"marketCap":1432545588},{"date":"2025-01-28","current":-7.264616,"twenty":-8.299451,"median":-7.229265,"eighty":-6.049174,"marketCap":1432545588},{"date":"2025-02-07","current":-7.236748,"twenty":-8.296655,"median":-7.256521,"eighty":-6.050501,"marketCap":1418976144},{"date":"2025-02-14","current":-6.936954,"twenty":-8.289567,"median":-7.234585,"eighty":-6.050566,"marketCap":1356944400},{"date":"2025-02-21","current":-6.209204,"twenty":-8.280918,"median":-7.193914,"eighty":-6.051176,"marketCap":1221249960},{"date":"2025-02-28","current":-5.735312,"twenty":-8.276823,"median":-7.189483,"eighty":-6.049174,"marketCap":1124325360},{"date":"2025-03-07","current":-4.382772,"twenty":-8.275728,"median":-7.147179,"eighty":-6.034591,"marketCap":862628940},{"date":"2025-03-14","current":-4.381178,"twenty":-8.27337,"median":-7.141207,"eighty":-6.005336,"marketCap":862628940},{"date":"2025-03-21","current":-4.382899,"twenty":-8.271865,"median":-7.139645,"eighty":-5.976203,"marketCap":862628940},{"date":"2025-03-28","current":-6.03007,"twenty":-8.267559,"median":-7.132215,"eighty":-5.958282,"marketCap":1184418612},{"date":"2025-04-03","current":-12.27285,"twenty":-8.275893,"median":-7.137062,"eighty":-5.959979,"marketCap":1279404720},{"date":"2025-04-11","current":-11.044555,"twenty":-8.297306,"median":-7.141207,"eighty":-5.971601,"marketCap":1143710280},{"date":"2025-04-17","current":-8.683774,"twenty":-8.301426,"median":-7.143912,"eighty":-5.986226,"marketCap":901398780},{"date":"2025-04-25","current":-8.769575,"twenty":-8.306866,"median":-7.147536,"eighty":-5.989499,"marketCap":911091240},{"date":"2025-05-02","current":-8.750975,"twenty":-8.320901,"median":-7.189649,"eighty":-5.997241,"marketCap":911091240},{"date":"2025-05-09","current":-8.320184,"twenty":-8.320865,"median":-7.193914,"eighty":-5.999307,"marketCap":872321400},{"date":"2025-05-16","current":-7.720916,"twenty":-8.320762,"median":-7.234585,"eighty":-6.005336,"marketCap":816105132},{"date":"2025-05-23","current":-7.734459,"twenty":-8.320415,"median":-7.256521,"eighty":-6.010152,"marketCap":819982116},{"date":"2025-05-30","current":-7.700604,"twenty":-8.317297,"median":-7.263991,"eighty":-6.01222,"marketCap":819982116},{"date":"2025-06-06","current":-7.681007,"twenty":-8.314485,"median":-7.286363,"eighty":-6.02333,"marketCap":819982116},{"date":"2025-06-13","current":-9.456792,"twenty":-8.320762,"median":-7.288884,"eighty":-6.03007,"marketCap":1009954332},{"date":"2025-06-20","current":-9.38443,"twenty":-8.354671,"median":-7.302687,"eighty":-6.032718,"marketCap":1000261872},{"date":"2025-06-27","current":-8.886685,"twenty":-8.370356,"median":-7.33658,"eighty":-6.034591,"marketCap":949861080},{"date":"2025-07-04","current":-8.886268,"twenty":-8.400619,"median":-7.39462,"eighty":-6.034663,"marketCap":949861080},{"date":"2025-07-11","current":-9.439834,"twenty":-8.450162,"median":-7.477671,"eighty":-6.037451,"marketCap":1008015840},{"date":"2025-07-18","current":-10.71898,"twenty":-8.504633,"median":-7.483524,"eighty":-6.043853,"marketCap":1143710280},{"date":"2025-07-25","current":-10.354306,"twenty":-8.575353,"median":-7.586326,"eighty":-6.04851,"marketCap":1108817424},{"date":"2025-08-01","current":-10.200109,"twenty":-8.700378,"median":-7.607601,"eighty":-6.050501,"marketCap":1085555520},{"date":"2025-08-08","current":-10.174658,"twenty":-8.73051,"median":-7.6347,"eighty":-6.050545,"marketCap":1085555520},{"date":"2025-08-15","current":-10.189926,"twenty":-8.755577,"median":-7.668855,"eighty":-6.050988,"marketCap":1085555520},{"date":"2025-08-22","current":-10.404516,"twenty":-8.778653,"median":-7.696508,"eighty":-6.053156,"marketCap":1104940440},{"date":"2025-08-29","current":-12.496435,"twenty":-8.886268,"median":-7.699076,"eighty":-6.05556,"marketCap":1066170600},{"date":"2025-09-05","current":-12.508831,"twenty":-8.917527,"median":-7.704882,"eighty":-6.055623,"marketCap":1066170600},{"date":"2025-09-12","current":-12.713379,"twenty":-9.283082,"median":-7.709288,"eighty":-6.056629,"marketCap":1085555520},{"date":"2025-09-19","current":-13.812899,"twenty":-9.372197,"median":-7.711903,"eighty":-6.091088,"marketCap":1178603136},{"date":"2025-09-26","current":-15.488824,"twenty":-9.421871,"median":-7.713577,"eighty":-6.168118,"marketCap":1318174560},{"date":"2025-10-03","current":-15.429223,"twenty":-9.439834,"median":-7.716349,"eighty":-6.209251,"marketCap":1316236068},{"date":"2025-10-10","current":-15.542765,"twenty":-9.48241,"median":-7.718907,"eighty":-6.209438,"marketCap":1323990036},{"date":"2025-10-17","current":-15.463777,"twenty":-9.516549,"median":-7.722508,"eighty":-6.564001,"marketCap":1316236068},{"date":"2025-10-24","current":-16.141138,"twenty":-9.993637,"median":-7.727404,"eighty":-6.587794,"marketCap":1374390828},{"date":"2025-10-31","current":-15.935241,"twenty":-10.174658,"median":-7.732892,"eighty":-6.604283,"marketCap":1358882892},{"date":"2025-11-07","current":-15.945201,"twenty":-10.180758,"median":-7.758053,"eighty":-6.609789,"marketCap":1358882892},{"date":"2025-11-14","current":-15.900146,"twenty":-10.200109,"median":-7.784219,"eighty":-6.614502,"marketCap":1358882892},{"date":"2025-11-21","current":-16.089098,"twenty":-10.29964,"median":-7.809695,"eighty":-6.640318,"marketCap":1374390828},{"date":"2025-11-28","current":-16.030869,"twenty":-10.386607,"median":-7.849274,"eighty":-6.646499,"marketCap":1374390828},{"date":"2025-12-05","current":-16.003355,"twenty":-10.404516,"median":-7.919793,"eighty":-6.658209,"marketCap":1374390828},{"date":"2025-12-12","current":-15.973808,"twenty":-10.577045,"median":-7.942728,"eighty":-6.66868,"marketCap":1374390828},{"date":"2025-12-19","current":-15.93625,"twenty":-10.714182,"median":-7.97694,"eighty":-6.670691,"marketCap":1374390828},{"date":"2025-12-24","current":-15.662693,"twenty":-10.90375,"median":-7.980005,"eighty":-6.674625,"marketCap":1355005908},{"date":"2026-01-02","current":-17.543083,"twenty":-11.095447,"median":-7.982691,"eighty":-6.684863,"marketCap":1523654712},{"date":"2026-01-09","current":-17.49951,"twenty":-11.336885,"median":-7.988022,"eighty":-6.703505,"marketCap":1523654712},{"date":"2026-01-16","current":-17.442827,"twenty":-12.451475,"median":-7.994219,"eighty":-6.740071,"marketCap":1523654712},{"date":"2026-01-23","current":-17.215232,"twenty":-12.506134,"median":-8.02019,"eighty":-6.870823,"marketCap":1502331300},{"date":"2026-01-30","current":-17.402236,"twenty":-12.672793,"median":-8.041443,"eighty":-6.879903,"marketCap":1525593204},{"date":"2026-02-06","current":-16.762691,"twenty":-13.116393,"median":-8.071832,"eighty":-6.881774,"marketCap":1473253920},{"date":"2026-02-13","current":-15.877471,"twenty":-13.767462,"median":-8.141386,"eighty":-6.889262,"marketCap":1403468208},{"date":"2026-02-20","current":-15.900374,"twenty":-14.02108,"median":-8.157515,"eighty":-6.889266,"marketCap":1403468208},{"date":"2026-02-27","current":-15.727885,"twenty":-14.413548,"median":-8.177364,"eighty":-6.902973,"marketCap":1403468208},{"date":"2026-03-02","current":-15.626367,"twenty":-14.567492,"median":-8.178873,"eighty":-6.907541,"marketCap":1386021780}],"updateTime":1772530064129},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02496\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608360867","title":"友芝友生物-B(02496)：公司H股全流通獲聯交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360867","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608360867?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 22:06","pubTimestamp":1770214006,"startTime":"0","endTime":"0","summary":"友芝友生物-B(02496)发布公告，公司已于2026年2月4日获联交所批准6801.03万股H股( \n相当于根据转换并上市将予转换的公司非上市股份总数 )上市及买卖。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_13.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_13.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"友芝友生物-B(02496)：公司H股全流通获联交所授出上市批准","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"1195242271","title":"友芝友生物-B宣佈M701獲FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1195242271","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195242271?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 00:36","pubTimestamp":1770136568,"startTime":"0","endTime":"0","summary":"2月3日，武汉友芝友生物制药股份有限公司（02496.HK）宣布，其研发的M701已获得美国食品药品监督管理局（FDA）的新药临床试验申请（IND）批准。此次获批标志着该药物可进入临床开发阶段，为公司创新药管线的国际化布局奠定重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2608824493","title":"友芝友生物-B(02496)：M 701取得FDA的IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2608824493","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608824493?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 18:09","pubTimestamp":1770113353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布公告，于2026年1月31日，注射用重组抗上皮细胞黏附分子和分化簇3人鼠嵌合双特异性抗体获美国食品药物管理局临床试验申请批准，标志着这款针对恶性胸腔积液的创新疗法迈入国际化临床开发新阶段，为全球患者带来新希望。M 701精准靶向Ep CAM和CD3，其中Ep CAM在上皮来源恶性胸腔积液肿瘤细胞中高频表达，是关键治疗靶点;CD3可激活机体抗肿瘤免疫，二者协同实现精准治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","IND","02496"],"gpt_icon":0},{"id":"2606766165","title":"友芝友生物-B盤中異動 急速上漲7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606766165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606766165?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 10:31","pubTimestamp":1769567516,"startTime":"0","endTime":"0","summary":"2026年01月28日早盘10时31分，友芝友生物-B股票出现异动，股价大幅拉升7.61%。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，友芝友生物-B、MIRXES-B、创胜集团-B涨幅较大，振幅较大的相关个股有旺山旺水-B、维亚生物、复宏汉霖，振幅分别为12.30%、7.60%、7.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128103156a6b53e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128103156a6b53e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2606221662","title":"友芝友生物-B(02496)：中國證監會就公司H股全流通發出備案通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2606221662","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606221662?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 18:01","pubTimestamp":1769421689,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布公告，本公司近期已就H股全流通向中国证监会提交备案。根据备案通知，有关转换并上市的中国证监会备案已告完成，倘本公司拟于备案通知发出日期起 12个月内未完成转换并上市，拟继续推进的，则需向中国证监会提交更新后的备案。截至本公告日期，H股全流通及转换并上市的实施计划详情尚未最终落实。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"友芝友生物-B(02496)：中国证监会就公司H股全流通发出备案通知","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2606301252","title":"友芝友生物(02496.HK)作價3,688萬人民幣出售武漢工業地","url":"https://stock-news.laohu8.com/highlight/detail?id=2606301252","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606301252?lang=zh_tw&edition=fundamental","pubTime":"2026-01-25 19:07","pubTimestamp":1769339220,"startTime":"0","endTime":"0","summary":"友芝友生物－Ｂ(02496.HK) 公布，向武汉依瑞德转让位于湖北省武汉市东、地盘面积约2,5533平方米的未使用工业用连建筑物，现金代价3,688万人民币。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498487/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498487/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02496","UCmain","MUCmain","CNHmain","CYB","MCNHmain"],"gpt_icon":0},{"id":"2605403773","title":"友芝友生物-B(02496)擬3688萬元轉讓武漢市東湖新技術開發區土地使用權及建築物","url":"https://stock-news.laohu8.com/highlight/detail?id=2605403773","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605403773?lang=zh_tw&edition=fundamental","pubTime":"2026-01-23 22:06","pubTimestamp":1769177198,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 公布，于2026年1月23日，武汉依瑞德与该公司订立转让协议，该公司拟向武汉依瑞德转让土地使用权及建筑物，代价约为人民币3688万元。据悉，土地及建筑物位于中国湖北省武汉市东湖新技术开发区高新三路以北、神墩三路以南，截至转让协议签署之日，土地的地盘面积约为25,533.4平方米，而建筑物的总楼面面积约为11,333.22平方米，为工业用途，土地使用权年期为50年，于2062年5月24日届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2603472416","title":"上市公司十強出爐，武大華科誰贏了","url":"https://stock-news.laohu8.com/highlight/detail?id=2603472416","media":"观一线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603472416?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 18:14","pubTimestamp":1768385680,"startTime":"0","endTime":"0","summary":"近日，中国上市公司协会发布报告，2025年A股上市公司总市值同比增长22.5%。其中，湖北A股上市公司总市值从1.45万亿元增长至约2.08万亿元，增幅约44%，显著高于全国平均水平。梳理湖北A股及港股上市公司的主要负责人，毕业于武汉大学的为15人，拥有华中科技大学教育背景的为20人。2025年湖北最后一家上市公司翰思艾泰，主要研发用于癌症及自身免疫疾病精准治疗的创新药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114193702a4c31c30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114193702a4c31c30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348825331.USD","LU0359201612.USD","LU1323998911.USD","LU0823039010.USD","LU0143863198.USD","IE0034224299.USD","LU0348735423.USD","LU1770034418.SGD","06869","LU0572944931.SGD","LU0254981946.USD","BK1587","LU0531970944.HKD","IE0032431581.USD","BK1607","LU0594300179.USD","LU0231483743.USD","LU1880383440.USD","600703","BK1523","300395","LU0244354667.USD","LU0700851271.USD","06690","LU0823041008.USD","LU0449515922.USD","LU0348816934.USD","BK1618","LU1719994722.HKD","LU1868837565.USD","LU0143863784.USD","HXXD.SI","BK1219","LU2097828557.USD","LU1282648689.USD","LU0650527681.SGD","LU2097828474.EUR","LU0210526637.USD","HK0000165453.HKD","LU0463099449.HKD","LU0039217434.USD","LU1105468828.SGD","LU1981816686.USD","LU0456846285.SGD","BK1575","LU0588546209.SGD","LU0449509016.USD","LU0084288322.USD","LU1770036033.HKD","LU1813983027.USD","LU0540923850.HKD","002414","LU0456827905.SGD","LU1303224171.USD","LU0320764599.SGD","LU0348827113.USD","LU0823413660.USD","LU0164872284.USD","LU1481107354.HKD","LU0823426308.USD","LU0675040207.SGD","601869","BK1521","LU2476274720.SGD","LU0359201885.HKD","BK1615","LU0594300419.USD","LU0823040885.USD","LU0611395673.USD","LU0307460666.USD","LU0918141887.USD","LU0052750758.USD","002281","SG9999002463.SGD","LU0708995583.HKD","SG9999003461.SGD","BK1193","02496","LU0051755006.USD","LU0211977185.USD","LU1868838027.USD","LU2097828631.EUR","LU2226246903.HKD","LU0605514214.HKD","LU0345776255.USD","LU0561508036.HKD","LU0417516738.SGD","600879","LU0169518387.USD","LU1328277881.USD","LU2778985437.USD","LU0499858602.USD","LU0117841782.USD","600690","81810","LU2257852520.SGD","BK1506","LU2152927971.USD","LU0823397103.USD","LU0823038988.USD","LU2039709279.SGD","LU0345775950.USD","LU0823413587.USD","LU0164880469.USD","LU0634319403.HKD","LU0823397285.USD","LU0823426480.USD","LU0871576103.HKD","LU1961090484.USD","LU0797268264.HKD","LU2097828714.EUR","LU1794554557.SGD","BK1589","LU0164865239.USD","MIUmain","LU0214875030.USD","LU2087589342.USD","BK1610","LU0348814723.USD","LU0314109678.HKD","LU0327786744.USD","LU1808992512.USD","LU1023057109.AUD","LU0149721374.USD","LU0326950275.SGD","IE00B3M56506.USD","LU2476274308.USD","LU1880383366.USD","LU0054450605.USD","LU0593848301.USD","LU1188198961.HKD","LU0235996351.USD","000708","LU0441854154.USD","LU1720050803.USD","LU0359202008.SGD","LU0417516902.SGD","LU1251922891.USD","LU0499858438.USD","LU0918141705.HKD","LU0531971595.HKD","SG9999001093.SGD","LU2399975544.HKD","LU2097828805.USD","BK1502","000988","LU1956131251.USD"],"gpt_icon":1},{"id":"2595787728","title":"友芝友生物-B(02496)：石劍獲選舉為職工代表監事","url":"https://stock-news.laohu8.com/highlight/detail?id=2595787728","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595787728?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 12:55","pubTimestamp":1767156917,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，王涛博士因个人职业发展原因而辞去公司职工代表监事职务，自2025年12月31日起生效。公司转化医学部总监石剑博士于2025年12月31日获民主选举为第二届监事会职工代表监事。石博士的任期自2025年12月31日起生效，并将于第二届监事会结束时届满。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2594022287","title":"友芝友生物(02496.HK)生物類似藥Y225臨床試驗申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2594022287","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594022287?lang=zh_tw&edition=fundamental","pubTime":"2025-12-28 18:39","pubTimestamp":1766918340,"startTime":"0","endTime":"0","summary":"友芝友生物－Ｂ(02496.HK) 公布，生物类似药Y225的临床试验申请获中国国国家药品监督管理局批准。Y225是一种用于治疗A型血友病的双特异性抗体舒友立乐(艾美赛珠单抗注射液，抗FIX和FX)生物类似药。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250730181922236_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250730181922236_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1492449/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1492449/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2593471543","title":"友芝友生物-B(02496)：Y225(艾美賽珠單抗注射液)取得NMPA的IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2593471543","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593471543?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 19:37","pubTimestamp":1766576227,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布公告，于2025年12月23日，其生物类似药Y225的临床试验申请已获中华人民共和国国家药品监督管理局批准。Y225是一种用于治疗A型血友病的双特异性抗体舒友立乐生物类似药。本次获批的临床试验是一项在健康成年人中进行的随机、双盲、单剂量、平行比较舒友立乐与Y225在健康男性受试者中的生物等效性临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IND","02496","BK1161"],"gpt_icon":0},{"id":"2588062835","title":"智通港股早知道 | 特朗普稱哈塞特為「潛在的」聯儲局主席 蘋果(AAPL.US)續創歷史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2588062835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588062835?lang=zh_tw&edition=fundamental","pubTime":"2025-12-03 07:13","pubTimestamp":1764717237,"startTime":"0","endTime":"0","summary":"美国总统特朗普称凯文·哈塞特为“潜在的”美联储主席智通财经APP获悉，美国总统特朗普周二表示，他计划在2026年初公布下一任美联储主席人选，并罕见地点名国家经济委员会主任凯文·哈塞特作为潜在候选人，使外界对美联储未来领导层的猜测进一步升温。该交易的完成仍有赖于获得惯常的监管批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1914381329.SGD","LU0056508442.USD","IVV","LU2247934214.USD","SDS","LU0345769128.USD","LU0672654240.SGD",".SPX","AAPL","MACW.SI","ESmain","LU0528227936.USD","SG9999015945.SGD","LU0348723411.USD","LU2087621335.USD","SPXU","BK4574","LU2271345857.HKD","SH","OEF","LU1935043536.SGD","LU0726765562.USD","LU2065171402.SGD","BK4532","UPRO","IE00B4JS1V06.HKD","SSO","LU0642271901.SGD","01729","BK4512","LU0683600562.USD","LU0787776722.HKD","SPY","MESmain","GB00BDT5M118.USD","LU2896262040.SGD","LU1823568750.SGD","BK4573","OEX","02533","LU0210536198.USD","LU2347655073.USD","02496","LU1868837300.USD","LU1066051811.HKD","LU0109392836.USD","LU2065170008.USD","BK4592"],"gpt_icon":1},{"id":"2588031469","title":"友芝友生物-B(02496)於《實驗血液學與腫瘤學》上發表M 701惡性腹水II期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2588031469","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588031469?lang=zh_tw&edition=fundamental","pubTime":"2025-12-02 18:09","pubTimestamp":1764670177,"startTime":"0","endTime":"0","summary":"II期研究旨在评估M701腹腔内输注疗法对出现中至大量恶性腹水的晚期上皮性肿瘤患者的疗效与安全性。本研究共纳入84名患者，其中43名患者被分配至M701组，接受腹腔穿刺及腹腔内M701输注。与对照组患者相比，M701组患者的总生存时间获得延长。在M701组别中未观察到任何其他严重不良反应事件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"友芝友生物-B(02496)于《实验血液学与肿瘤学》上发表M 701恶性腹水II期数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2583665794","title":"深耕雙抗領域15年，友芝友生物周鵬飛：中國創新藥正在走向產業高潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2583665794","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583665794?lang=zh_tw&edition=fundamental","pubTime":"2025-11-15 13:56","pubTimestamp":1763186186,"startTime":"0","endTime":"0","summary":"M701即将申请上市，友芝友生物将其中国区权益以超过20亿元的预期销售额转让给正大天晴，自己保留海外权益和销售提成。在双抗领域的蓝海中，周鹏飞和他的团队正以坚定的步伐，书写着中国生物医药创新的新篇章。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511151404519505db72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511151404519505db72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1574","06978","BK1161"],"gpt_icon":0},{"id":"2578263728","title":"新藥周觀點：ESMO2025國產新藥精彩紛呈","url":"https://stock-news.laohu8.com/highlight/detail?id=2578263728","media":"安信证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578263728?lang=zh_tw&edition=fundamental","pubTime":"2025-10-26 00:00","pubTimestamp":1761408000,"startTime":"0","endTime":"0","summary":"近日2025 年欧洲肿瘤内科学会年会于10 月17 日至21 日在德国柏林举行，科伦博泰、百利天恒、康方生物、恒瑞医药等多个国内企业在上述会议披露了多个优异临床数据，国产新药精彩纷呈。本周新药临床申请获批准&受理情况：本周国内有46 个新药的临床申请获批准，有31 个新药的临床申请获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102620513994de39af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102620513994de39af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","02496","BK1161","LU1969619763.USD","LU0502904849.HKD","LU0455707207.USD","LU2097828474.EUR","LU2488822045.USD","01801","BK1589","LU2242644610.SGD","LU2328871848.SGD","02105","LU2097828805.USD","BK1583","02511","LU2097828557.USD","LU2097828714.EUR","LU2097828631.EUR"],"gpt_icon":1},{"id":"2577832867","title":"ORR 72.7%！友芝友生物EpCAM×CD3雙抗II期研究中期數據公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2577832867","media":"生物药大时代","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577832867?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 11:28","pubTimestamp":1760930924,"startTime":"0","endTime":"0","summary":"2025年10月19日，武汉友芝友生物制药股份有限公司宣布，公司自主研发的上皮细胞黏附分子和分化簇3双靶向的在研双特异性抗体药物M701在中国开展的治疗晚期非小细胞肺癌引发的恶性胸水的II期临床研究的中期数据已以大会壁报的形式在2025年欧洲肿瘤内科学会会议上公布。正大天晴将根据研发进展情况，向友芝友生物支付约3.15亿元的首付款及研发里程碑款项，并支付最高不超过7亿元的销售里程碑款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020113325a4694450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020113325a4694450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2576078087","title":"友芝友生物-B(02496)：M701惡性胸水II期研究中期數據在2025年ESMO會議上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2576078087","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576078087?lang=zh_tw&edition=fundamental","pubTime":"2025-10-19 18:19","pubTimestamp":1760869192,"startTime":"0","endTime":"0","summary":"本研究是一项针对晚期非小细胞肺癌导致的恶性胸水的随机对照、多中心、开放式的II期临床试验。试验组受试者在胸腔穿刺引流后，给予胸腔灌注M701药物。截至2025年3月7日，54名筛选合格的经至少一线全身治疗后病情进展、有症状性恶性胸水的晚期非小细胞肺癌患者，按照1:1随机分组，试验组26名，对照组28名。安全性结果：M701治疗相关不良事件发生率为3.7%，顺铂组为10%，仅1例严重不良事件与M701相关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2570758200","title":"友芝友生物-B盤中異動 早盤快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570758200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570758200?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 11:26","pubTimestamp":1758857191,"startTime":"0","endTime":"0","summary":"2025年09月26日早盘11时26分，友芝友生物-B股票出现异动，股价急速上涨5.24%。截至发稿，该股报6.630港元/股，成交量6200股，换手率0.01%，振幅5.24%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体跌幅为2.59%。其相关个股中，云康集团、来凯医药-B、友芝友生物-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、创胜集团-B、来凯医药-B，振幅分别为13.57%、11.09%、9.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926112631a69f04c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926112631a69f04c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2568427724","title":"友芝友生物-B(02496)：王濤獲選舉為職工代表監事","url":"https://stock-news.laohu8.com/highlight/detail?id=2568427724","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568427724?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 16:50","pubTimestamp":1758185448,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，张敬先生因个人职业发展原因而辞去公司职工代表监事职务，自2025年9月18日起生效。公司研发平台部执行总监王涛博士于2025年9月18日获民主选举为第二届监事会职工代表监事。王涛博士的任期自2025年9月18日起生效，并将于第二届监事会结束时届满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2562849397","title":"友芝友生物-B(02496)發布中期業績，淨虧損5883.4萬元，按年收窄25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562849397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562849397?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 17:43","pubTimestamp":1756201421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布截至2025年6月30日止六个月业绩，收入3718.7万元;净亏损5883.4万元，同比收窄25%;每股基本亏损0.30元。许可费收入主要是公司与正大天晴签订了一项许可合作协定。截至2025年6月30日止六个月，集团就授予许可使用权以实现发展里程碑确认收入470万元。在截至2025年6月30日止六个月，公司根据满足履约义务所付出的努力或投入与预计为满足该履约义务所需的总投入之间的相对比例按进度确认了3250万元的研发服务收入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}